In the mid 1990s I attended a conference on medical treatment of obesity where many of the participants were nearly giddy with excitement. The FDA had just approved Redux (fenfluramine), an appetite suppressant which, combined with an older drug, phentermine, became the wildly popular “Fen-Phen.” Doctors listened eagerly to lectures about this drug, which might […]
